Provided by Tiger Fintech (Singapore) Pte. Ltd.

Generation Bio Co.

0.4999
-0.0201-3.87%
Volume:383.17K
Turnover:195.22K
Market Cap:33.39M
PE:-0.23
High:0.5350
Open:0.5117
Low:0.4951
Close:0.5200
Loading ...

Company Profile

Company Name:
Generation Bio Co.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
174
Office Location:
301 Binney Street,Cambridge,Massachusetts,United States
Zip Code:
02142
Fax:
- -
Introduction:
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Directors

Name
Position
Geoff McDonough
President and Chief Executive Officer, Director
Jason Rhodes
Chairman of the Board of Director
Anthony Quinn
Director
Catherine Stehman Breen
Director
Charles Rowland
Director
Donald Nicholson
Director
Gustav Christensen
Director
Jeffrey Jonas
Director

Shareholders

Name
Position
Geoff McDonough
President and Chief Executive Officer, Director
Mark Angelino
Chief Operating Officer
Stephen DiPalma
Interim Chief Financial Officer
Douglas Kerr
Chief Development Officer
Matthew Stanton
Chief Scientific Officer